ALLARITY THERAPEUTICS, INC. — Income Charts
5 quarters of history · ending 2021-09-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-87.3% -$193K
$28K
Cost of Revenue
—
Gross Profit
—
R&D↑+72.6% +$570K
$1M
D&A↑+136.8% +$52K
$90K
Operating Income↓-128.7% -$2M
$-4M
EBITDA↓-128.5% -$2M
$-4M
Interest Expense↑+17.4% +$4K
$27K
Interest Income
$28K
Other Income/Expense
—
Pretax Income
—
Tax Provision↓-30.0% -$15K
$35K
Net Income↑+9.8% +$147K
$-1M
Operating Margin↓-13406.4pts
-14192.9%
Net Margin↓-4147.2pts
-4825.0%
Effective Tax Rate
—
Deferred Tax Liabilities
$603K
ETR (Continuing Operations)
—
ETR Federal Statutory
—
Revenue YoY Variation
-87.3%
Income YoY Variation
-128.7%
Revenue QoQ Variation
107.1%
Income QoQ Variation
9.2%